Transcatheter aortic-valve implantation (TAVI) was a hot topic at EuroPCR 2010, where our multidisciplinary panel of experts met to discuss how the procedure will be fine-tuned in the coming five to 10 years. In this thoughtful discussion, Drs Leon, Cribier, Moat, and Ruiz share their predictions and wish lists on a variety of subjects, including: What technology changes are necessary? Should future patient selection include lower-risk candidates? Who will perform future TAVI procedures? Will the "heart-valve team" survive in its current form? Where will TAVI procedures be performed? What about durability? What data do we need from new clinical trials?